25 XP   0   0   10

Profarma Distribuidora de Produtos Farmacêuticos S.A
Buy, Hold or Sell?

Let's analyse Profarma together

PenkeI guess you are interested in Profarma Distribuidora de Produtos Farmacêuticos S.A. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Profarma Distribuidora de Produtos Farmacêuticos S.A. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Profarma Distribuidora de Produtos Farmacêuticos S.A

I send you an email if I find something interesting about Profarma Distribuidora de Produtos Farmacêuticos S.A.

Quick analysis of Profarma (30 sec.)










What can you expect buying and holding a share of Profarma? (30 sec.)

How much money do you get?

How much money do you get?
R$0.14
When do you have the money?
1 year
How often do you get paid?
27.5%

What is your share worth?

Current worth
R$12.55
Expected worth in 1 year
R$12.78
How sure are you?
55.0%

+ What do you gain per year?

Total Gains per Share
R$0.94
Return On Investment
15.1%

For what price can you sell your share?

Current Price per Share
R$6.27
Expected price per share
R$5.18 - R$
How sure are you?
50%

1. Valuation of Profarma (5 min.)




Live pricePrice per Share (EOD)

R$6.27

Intrinsic Value Per Share

R$2.01 - R$27.18

Total Value Per Share

R$14.56 - R$39.73

2. Growth of Profarma (5 min.)




Is Profarma growing?

Current yearPrevious yearGrowGrow %
How rich?$299m$291.5m$5.5m1.9%

How much money is Profarma making?

Current yearPrevious yearGrowGrow %
Making money$3.3m$3.7m-$375.9k-11.1%
Net Profit Margin0.8%1.0%--

How much money comes from the company's main activities?

3. Financial Health of Profarma (5 min.)




4. Comparing to competitors in the Medical Distribution industry (5 min.)




  Industry Rankings (Medical Distribution)  


Richest
#22 / 41

Most Revenue
#22 / 41

Most Profit
#23 / 41

What can you expect buying and holding a share of Profarma? (5 min.)

Welcome investor! Profarma's management wants to use your money to grow the business. In return you get a share of Profarma.

What can you expect buying and holding a share of Profarma?

First you should know what it really means to hold a share of Profarma. And how you can make/lose money.

Speculation

The Price per Share of Profarma is R$6.27. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Profarma.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Profarma, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is R$12.55. Based on the TTM, the Book Value Change Per Share is R$0.06 per quarter. Based on the YOY, the Book Value Change Per Share is R$0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is R$0.18 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Profarma.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 R$% of Price per ShareR$% of Price per ShareR$% of Price per ShareR$% of Price per ShareR$% of Price per Share
Usd Eps0.050.7%0.030.4%0.030.5%0.020.4%0.000.0%
Usd Book Value Change Per Share-0.02-0.4%0.010.2%0.010.2%0.040.7%0.040.6%
Usd Dividend Per Share0.050.8%0.030.6%0.000.0%0.020.3%0.010.1%
Usd Total Gains Per Share0.030.4%0.050.7%0.010.2%0.060.9%0.050.7%
Usd Price Per Share1.19-0.84-0.76-0.94-1.31-
Price to Earnings Ratio6.58--0.40-3.00--154.18--21.17-
Price-to-Total Gains Ratio46.33-25.88-0.04--616.83--217.02-
Price to Book Ratio0.49-0.34-0.32-0.46-0.95-
Price-to-Total Gains Ratio46.33-25.88-0.04--616.83--217.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.218261
Number of shares820
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.02
Usd Book Value Change Per Share0.010.04
Usd Total Gains Per Share0.050.06
Gains per Quarter (820 shares)37.6446.89
Gains per Year (820 shares)150.54187.56
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
11143714153135178
222774292106269366
3341111443159404554
4454148594212538742
5568185745265673930
66822228963188071118
779525910473719421306
8909296119842410771494
91022333134947712111682
101136369150053013461870

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share3.01.00.075.0%10.02.00.083.3%15.05.00.075.0%20.020.00.050.0%52.021.01.070.3%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%12.08.00.060.0%19.021.00.047.5%47.026.01.063.5%
Dividend per Share4.00.00.0100.0%8.00.04.066.7%8.00.012.040.0%11.00.029.027.5%35.00.039.047.3%
Total Gains per Share4.00.00.0100.0%10.02.00.083.3%15.05.00.075.0%22.018.00.055.0%53.020.01.071.6%

Fundamentals of Profarma

About Profarma Distribuidora de Produtos Farmacêuticos S.A

Profarma Distribuidora de Produtos Farmacêuticos S.A., together with its subsidiaries, engages in the distribution and retail sale of pharmaceutical products in Brazil. The company operates through two segments, Distribution and Retail segments. It provides medicines, human drugs, personal hygiene, veterinary, perfumery, and cosmetic and beauty products. The company operates retail stores under the Drogasmil, Farmalife, Tamoio, and Rede Rosário brands. Profarma Distribuidora de Produtos Farmacêuticos S.A. was incorporated in 1961 and is headquartered in Rio De Janeiro, Brazil.

Fundamental data was last updated by Penke on 2024-04-24 11:34:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is not making a profit/loss.
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is unable to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Profarma Distribuidora de Produtos Farmacêuticos S.A.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Profarma earns for each R$1 of revenue.

  • Above 10% is considered healthy but always compare Profarma to the Medical Distribution industry mean.
  • A Net Profit Margin of 1.3% means that R$0.01 for each R$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The MRQ is 1.3%. The company is making a profit. +1
  • The TTM is 0.8%. The company is not making a profit/loss.
Trends
Current periodCompared to+/- 
MRQ1.3%TTM0.8%+0.5%
TTM0.8%YOY1.0%-0.2%
TTM0.8%5Y0.8%0.0%
5Y0.8%10Y-0.2%+1.0%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.3%2.0%-0.7%
TTM0.8%2.1%-1.3%
YOY1.0%2.5%-1.5%
5Y0.8%2.2%-1.4%
10Y-0.2%2.3%-2.5%
1.1.2. Return on Assets

Shows how efficient Profarma is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Profarma to the Medical Distribution industry mean.
  • 0.6% Return on Assets means that Profarma generated R$0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The MRQ is 0.6%. Using its assets, the company is inefficient in making profit. -1
  • The TTM is 0.4%. Using its assets, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ0.6%TTM0.4%+0.2%
TTM0.4%YOY0.5%-0.1%
TTM0.4%5Y0.4%+0.0%
5Y0.4%10Y-0.1%+0.4%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6%1.1%-0.5%
TTM0.4%1.1%-0.7%
YOY0.5%1.1%-0.6%
5Y0.4%1.0%-0.6%
10Y-0.1%1.3%-1.4%
1.1.3. Return on Equity

Shows how efficient Profarma is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Profarma to the Medical Distribution industry mean.
  • 2.3% Return on Equity means Profarma generated R$0.02 for each R$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The MRQ is 2.3%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 1.4%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ2.3%TTM1.4%+0.9%
TTM1.4%YOY1.6%-0.2%
TTM1.4%5Y1.3%+0.1%
5Y1.3%10Y-0.2%+1.5%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.3%2.6%-0.3%
TTM1.4%2.4%-1.0%
YOY1.6%2.4%-0.8%
5Y1.3%2.4%-1.1%
10Y-0.2%3.0%-3.2%

1.2. Operating Efficiency of Profarma Distribuidora de Produtos Farmacêuticos S.A.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Profarma is operating .

  • Measures how much profit Profarma makes for each R$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Profarma to the Medical Distribution industry mean.
  • An Operating Margin of 2.8% means the company generated R$0.03  for each R$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The MRQ is 2.8%. The company is operating less efficient.
  • The TTM is 2.5%. The company is operating less efficient.
Trends
Current periodCompared to+/- 
MRQ2.8%TTM2.5%+0.3%
TTM2.5%YOY2.9%-0.4%
TTM2.5%5Y2.5%+0.0%
5Y2.5%10Y1.8%+0.7%
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8%2.9%-0.1%
TTM2.5%2.6%-0.1%
YOY2.9%3.5%-0.6%
5Y2.5%3.5%-1.0%
10Y1.8%3.1%-1.3%
1.2.2. Operating Ratio

Measures how efficient Profarma is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • An Operation Ratio of 0.97 means that the operating costs are R$0.97 for each R$1 in net sales.

Let's take a look of the Operating Ratio trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The MRQ is 0.972. The company is less efficient in keeping operating costs low.
  • The TTM is 0.980. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ0.972TTM0.980-0.008
TTM0.980YOY0.969+0.011
TTM0.9805Y0.979+0.001
5Y0.97910Y0.985-0.005
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9721.642-0.670
TTM0.9801.573-0.593
YOY0.9691.431-0.462
5Y0.9791.365-0.386
10Y0.9851.229-0.244

1.3. Liquidity of Profarma Distribuidora de Produtos Farmacêuticos S.A.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Profarma is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Distribution industry mean).
  • A Current Ratio of 1.45 means the company has R$1.45 in assets for each R$1 in short-term debts.

Let's take a look of the Current Ratio trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The MRQ is 1.447. The company is just able to pay all its short-term debts.
  • The TTM is 1.400. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.447TTM1.400+0.047
TTM1.400YOY1.447-0.048
TTM1.4005Y1.411-0.012
5Y1.41110Y1.461-0.050
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4471.359+0.088
TTM1.4001.4000.000
YOY1.4471.424+0.023
5Y1.4111.411+0.000
10Y1.4611.329+0.132
1.3.2. Quick Ratio

Measures if Profarma is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Profarma to the Medical Distribution industry mean.
  • A Quick Ratio of 0.81 means the company can pay off R$0.81 for each R$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The MRQ is 0.810. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.786. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.810TTM0.786+0.024
TTM0.786YOY0.816-0.030
TTM0.7865Y0.792-0.006
5Y0.79210Y0.912-0.120
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.8100.746+0.064
TTM0.7860.757+0.029
YOY0.8160.818-0.002
5Y0.7920.784+0.008
10Y0.9120.850+0.062

1.4. Solvency of Profarma Distribuidora de Produtos Farmacêuticos S.A.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Profarma assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Profarma to Medical Distribution industry mean.
  • A Debt to Asset Ratio of 0.69 means that Profarma assets are financed with 68.8% credit (debt) and the remaining percentage (100% - 68.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The MRQ is 0.688. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.679. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.688TTM0.679+0.010
TTM0.679YOY0.654+0.025
TTM0.6795Y0.662+0.017
5Y0.66210Y0.6620.000
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6880.610+0.078
TTM0.6790.606+0.073
YOY0.6540.600+0.054
5Y0.6620.580+0.082
10Y0.6620.592+0.070
1.4.2. Debt to Equity Ratio

Measures if Profarma is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Profarma to the Medical Distribution industry mean.
  • A Debt to Equity ratio of 272.3% means that company has R$2.72 debt for each R$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The MRQ is 2.723. The company is unable to pay all its debts with equity. -1
  • The TTM is 2.642. The company is unable to pay all its debts with equity. -1
Trends
Current periodCompared to+/- 
MRQ2.723TTM2.642+0.081
TTM2.642YOY2.444+0.198
TTM2.6425Y2.379+0.263
5Y2.37910Y2.191+0.188
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
MRQ2.7231.554+1.169
TTM2.6421.562+1.080
YOY2.4441.697+0.747
5Y2.3791.675+0.704
10Y2.1911.760+0.431

2. Market Valuation of Profarma Distribuidora de Produtos Farmacêuticos S.A

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every R$1 in earnings Profarma generates.

  • Above 15 is considered overpriced but always compare Profarma to the Medical Distribution industry mean.
  • A PE ratio of 6.58 means the investor is paying R$6.58 for every R$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The EOD is 6.764. Based on the earnings, the company is cheap. +2
  • The MRQ is 6.580. Based on the earnings, the company is cheap. +2
  • The TTM is -0.397. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.764MRQ6.580+0.183
MRQ6.580TTM-0.397+6.978
TTM-0.397YOY3.001-3.399
TTM-0.3975Y-154.179+153.781
5Y-154.17910Y-21.166-133.013
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD6.76411.686-4.922
MRQ6.58012.660-6.080
TTM-0.39715.740-16.137
YOY3.00118.574-15.573
5Y-154.17915.472-169.651
10Y-21.16619.669-40.835
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The EOD is 14.142. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 13.759. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 4.278. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD14.142MRQ13.759+0.383
MRQ13.759TTM4.278+9.481
TTM4.278YOY-0.009+4.287
TTM4.2785Y-0.387+4.665
5Y-0.38710Y69.540-69.927
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD14.1426.479+7.663
MRQ13.7597.076+6.683
TTM4.2787.751-3.473
YOY-0.0090.640-0.649
5Y-0.3872.246-2.633
10Y69.5401.985+67.555
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Profarma is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Distribution industry mean).
  • A PB ratio of 0.49 means the investor is paying R$0.49 for each R$1 in book value.

Let's take a look of the Price to Book Ratio trends of Profarma Distribuidora de Produtos Farmacêuticos S.A:

  • The EOD is 0.500. Based on the equity, the company is cheap. +2
  • The MRQ is 0.486. Based on the equity, the company is cheap. +2
  • The TTM is 0.344. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD0.500MRQ0.486+0.014
MRQ0.486TTM0.344+0.142
TTM0.344YOY0.320+0.024
TTM0.3445Y0.457-0.113
5Y0.45710Y0.950-0.493
Compared to industry (Medical Distribution)
PeriodCompanyIndustry (mean)+/- 
EOD0.5000.958-0.458
MRQ0.4861.158-0.672
TTM0.3441.158-0.814
YOY0.3201.208-0.888
5Y0.4571.257-0.800
10Y0.9501.922-0.972
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Profarma Distribuidora de Produtos Farmacêuticos S.A compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.1230.058-312%0.071-274%0.211-158%0.197-162%
Book Value Per Share--12.55212.470+1%12.237+3%10.928+15%8.665+45%
Current Ratio--1.4471.400+3%1.4470%1.411+3%1.461-1%
Debt To Asset Ratio--0.6880.679+1%0.654+5%0.662+4%0.662+4%
Debt To Equity Ratio--2.7232.642+3%2.444+11%2.379+14%2.191+24%
Dividend Per Share--0.2550.178+43%-+100%0.083+206%0.044+480%
Eps--0.2320.144+61%0.165+41%0.120+93%0.010+2217%
Free Cash Flow Per Share--0.1110.349-68%0.114-3%0.149-26%0.025+347%
Free Cash Flow To Equity Per Share--0.1480.052+184%-0.110+174%-0.016+111%0.063+133%
Gross Profit Margin---9.034-3.559-61%-9.665+7%88.025-110%30.237-130%
Intrinsic Value_10Y_max--27.177--------
Intrinsic Value_10Y_min--2.013--------
Intrinsic Value_1Y_max--1.027--------
Intrinsic Value_1Y_min--0.117--------
Intrinsic Value_3Y_max--4.379--------
Intrinsic Value_3Y_min--0.428--------
Intrinsic Value_5Y_max--9.290--------
Intrinsic Value_5Y_min--0.818--------
Market Cap768770970.000+3%747927100.000527227300.000+42%479102482.500+56%591904602.500+26%825601168.500-9%
Net Profit Margin--0.0130.008+66%0.010+32%0.008+57%-0.002+117%
Operating Margin--0.0280.025+12%0.029-3%0.025+13%0.018+58%
Operating Ratio--0.9720.980-1%0.969+0%0.979-1%0.985-1%
Pb Ratio0.500+3%0.4860.344+41%0.320+52%0.457+6%0.950-49%
Pe Ratio6.764+3%6.580-0.397+106%3.001+119%-154.179+2443%-21.166+422%
Price Per Share6.270+3%6.1004.300+42%3.908+56%4.828+26%6.734-9%
Price To Free Cash Flow Ratio14.142+3%13.7594.278+222%-0.009+100%-0.387+103%69.540-80%
Price To Total Gains Ratio47.620+3%46.32825.876+79%0.036+126921%-616.834+1431%-217.017+568%
Quick Ratio--0.8100.786+3%0.816-1%0.792+2%0.912-11%
Return On Assets--0.0060.004+57%0.005+26%0.004+64%-0.001+114%
Return On Equity--0.0230.014+63%0.016+39%0.013+78%-0.002+108%
Total Gains Per Share--0.1320.236-44%0.071+86%0.294-55%0.241-45%
Usd Book Value--299032557.500297078142.375+1%291522279.600+3%260335021.445+15%206427924.265+45%
Usd Book Value Change Per Share---0.0240.011-312%0.014-274%0.041-158%0.038-162%
Usd Book Value Per Share--2.4392.423+1%2.378+3%2.123+15%1.684+45%
Usd Dividend Per Share--0.0490.035+43%-+100%0.016+206%0.009+480%
Usd Eps--0.0450.028+61%0.032+41%0.023+93%0.002+2217%
Usd Free Cash Flow--2640537.0008317254.375-68%2713399.500-3%3549870.715-26%590395.123+347%
Usd Free Cash Flow Per Share--0.0220.068-68%0.022-3%0.029-26%0.005+347%
Usd Free Cash Flow To Equity Per Share--0.0290.010+184%-0.021+174%-0.003+111%0.012+133%
Usd Market Cap149372199.471+3%145322235.530102440264.390+42%93089612.350+56%115007064.266+26%160414307.040-9%
Usd Price Per Share1.218+3%1.1850.835+42%0.759+56%0.938+26%1.308-9%
Usd Profit--5521034.5003390097.825+63%3766068.325+47%2815659.590+96%219121.825+2420%
Usd Revenue--428826706.200420744214.800+2%379672789.350+13%322283408.710+33%255235239.060+68%
Usd Total Gains Per Share--0.0260.046-44%0.014+86%0.057-55%0.047-45%
 EOD+4 -4MRQTTM+22 -14YOY+21 -155Y+22 -1410Y+23 -13

3.2. Fundamental Score

Let's check the fundamental score of Profarma Distribuidora de Produtos Farmacêuticos S.A based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-156.764
Price to Book Ratio (EOD)Between0-10.500
Net Profit Margin (MRQ)Greater than00.013
Operating Margin (MRQ)Greater than00.028
Quick Ratio (MRQ)Greater than10.810
Current Ratio (MRQ)Greater than11.447
Debt to Asset Ratio (MRQ)Less than10.688
Debt to Equity Ratio (MRQ)Less than12.723
Return on Equity (MRQ)Greater than0.150.023
Return on Assets (MRQ)Greater than0.050.006
Total6/10 (60.0%)

3.3. Technical Score

Let's check the technical score of Profarma Distribuidora de Produtos Farmacêuticos S.A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.356
Ma 20Greater thanMa 505.573
Ma 50Greater thanMa 1005.458
Ma 100Greater thanMa 2005.278
OpenGreater thanClose6.070
Total4/5 (80.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in BRL. All numbers in thousands.

Summary
Total Assets4,937,926
Total Liabilities3,398,901
Total Stockholder Equity1,248,348
 As reported
Total Liabilities 3,398,901
Total Stockholder Equity+ 1,248,348
Total Assets = 4,937,926

Assets

Total Assets4,937,926
Total Current Assets3,539,367
Long-term Assets1,398,559
Total Current Assets
Cash And Cash Equivalents 193,743
Net Receivables 1,787,912
Inventory 1,527,620
Other Current Assets 30,092
Total Current Assets  (as reported)3,539,367
Total Current Assets  (calculated)3,539,367
+/-0
Long-term Assets
Property Plant Equipment 535,590
Goodwill 483,160
Intangible Assets 177,668
Long-term Assets Other 15,927
Long-term Assets  (as reported)1,398,559
Long-term Assets  (calculated)1,212,345
+/- 186,214

Liabilities & Shareholders' Equity

Total Current Liabilities2,446,645
Long-term Liabilities952,256
Total Stockholder Equity1,248,348
Total Current Liabilities
Short-term Debt 298,788
Short Long Term Debt 206,276
Accounts payable 1,869,847
Other Current Liabilities 246,601
Total Current Liabilities  (as reported)2,446,645
Total Current Liabilities  (calculated)2,621,512
+/- 174,867
Long-term Liabilities
Long term Debt 573,628
Capital Lease Obligations 363,794
Long-term Liabilities  (as reported)952,256
Long-term Liabilities  (calculated)937,422
+/- 14,834
Total Stockholder Equity
Common Stock1,043,663
Retained Earnings 180,071
Accumulated Other Comprehensive Income 221,052
Other Stockholders Equity -196,438
Total Stockholder Equity (as reported)1,248,348
Total Stockholder Equity (calculated)1,248,348
+/-0
Other
Capital Stock1,043,663
Cash and Short Term Investments 193,743
Common Stock Shares Outstanding 122,611
Current Deferred Revenue31,409
Liabilities and Stockholders Equity 4,937,926
Net Debt 949,955
Net Invested Capital 2,028,252
Net Working Capital 1,092,722
Property Plant and Equipment Gross 1,178,672
Short Long Term Debt Total 1,143,698



Balance Sheet

Currency in BRL. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-03-312004-12-312003-12-31
> Total Assets 
268,109
336,336
0
425,920
425,354
420,173
504,570
776,560
767,594
778,555
776,509
927,734
863,881
905,031
928,542
915,485
879,341
859,029
853,079
951,283
997,549
862,230
945,820
1,070,574
1,092,723
1,002,264
982,576
1,227,338
1,291,713
1,216,248
1,205,674
1,430,602
1,616,854
1,650,909
1,744,872
1,778,666
1,717,911
1,842,184
1,765,939
1,828,215
2,002,489
1,868,667
1,990,011
2,282,159
2,356,714
2,332,256
2,256,051
2,712,233
2,855,590
2,806,778
2,635,955
2,619,492
2,677,012
2,702,153
2,711,211
2,890,224
3,013,728
3,050,833
3,149,602
3,183,388
3,585,670
3,398,827
3,677,478
3,761,067
4,123,665
3,944,597
3,838,715
4,032,894
4,511,044
4,300,476
4,178,752
4,364,933
4,796,852
4,618,095
4,686,426
4,937,926
4,937,9264,686,4264,618,0954,796,8524,364,9334,178,7524,300,4764,511,0444,032,8943,838,7153,944,5974,123,6653,761,0673,677,4783,398,8273,585,6703,183,3883,149,6023,050,8333,013,7282,890,2242,711,2112,702,1532,677,0122,619,4922,635,9552,806,7782,855,5902,712,2332,256,0512,332,2562,356,7142,282,1591,990,0111,868,6672,002,4891,828,2151,765,9391,842,1841,717,9111,778,6661,744,8721,650,9091,616,8541,430,6021,205,6741,216,2481,291,7131,227,338982,5761,002,2641,092,7231,070,574945,820862,230997,549951,283853,079859,029879,341915,485928,542905,031863,881927,734776,509778,555767,594776,560504,570420,173425,354425,9200336,336268,109
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
875,752
0
0
805,500
901,150
948,581
802,738
0
1,001,648
1,024,097
929,413
914,738
1,140,681
1,205,431
1,121,636
1,103,433
1,299,598
1,485,421
1,406,631
1,319,559
1,317,979
1,258,308
1,377,665
1,296,374
1,347,530
1,522,508
1,389,157
1,483,598
1,642,637
1,713,459
1,650,098
1,565,975
1,692,956
1,826,477
1,754,416
1,637,918
1,645,464
1,688,264
1,717,386
1,760,260
1,953,156
1,883,544
1,923,238
2,021,043
2,095,792
2,457,987
2,226,747
2,486,827
2,484,144
2,810,656
2,586,093
2,441,330
2,582,007
3,081,866
2,934,354
2,814,830
2,980,433
3,421,118
3,251,876
3,312,702
3,539,367
3,539,3673,312,7023,251,8763,421,1182,980,4332,814,8302,934,3543,081,8662,582,0072,441,3302,586,0932,810,6562,484,1442,486,8272,226,7472,457,9872,095,7922,021,0431,923,2381,883,5441,953,1561,760,2601,717,3861,688,2641,645,4641,637,9181,754,4161,826,4771,692,9561,565,9751,650,0981,713,4591,642,6371,483,5981,389,1571,522,5081,347,5301,296,3741,377,6651,258,3081,317,9791,319,5591,406,6311,485,4211,299,5981,103,4331,121,6361,205,4311,140,681914,738929,4131,024,0971,001,6480802,738948,581901,150805,50000875,752000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
44,914
0
0
51,787
19,154
43,663
34,860
0
11,642
11,277
8,506
20,735
22,888
10,638
21,932
14,096
49,327
118,691
80,723
57,580
59,582
114,295
264,851
162,081
174,097
255,945
139,274
146,644
253,048
203,367
131,214
159,619
205,506
293,261
257,800
250,623
193,172
298,713
194,969
197,293
229,160
141,506
228,126
244,854
225,816
270,821
386,698
521,361
371,792
232,601
254,082
187,294
188,517
146,819
196,552
116,521
183,255
167,468
156,224
178,029
193,743
193,743178,029156,224167,468183,255116,521196,552146,819188,517187,294254,082232,601371,792521,361386,698270,821225,816244,854228,126141,506229,160197,293194,969298,713193,172250,623257,800293,261205,506159,619131,214203,367253,048146,644139,274255,945174,097162,081264,851114,29559,58257,58080,723118,69149,32714,09621,93210,63822,88820,7358,50611,27711,642034,86043,66319,15451,7870044,914000000000000000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-11,445
-24,365
0
540
340
7,002
-22,944
8,920
5,661
17
5,828
12,946
-30,625
873
42,813
28,285
-30,615
528,001
530,159
-36,604
-35,408
0
794,739
3
-29,022
24,423
17,544
8,911
306
2,347
11,951
4,524
59,244
72,603
49,478
23,063
22,822
0
2,299
10,601
2,426
11,163
4,132
-44,652
-43,503
-35,648
1,326
0
01,326-35,648-43,503-44,6524,13211,1632,42610,6012,299022,82223,06349,47872,60359,2444,52411,9512,3473068,91117,54424,423-29,0223794,7390-35,408-36,604530,159528,001-30,61528,28542,813873-30,62512,9465,828175,6618,920-22,9447,0023405400-24,365-11,4450000000000000000000000000000
       Net Receivables 
149,008
195,677
0
255,044
250,098
267,938
317,810
351,320
396,751
429,344
466,105
510,357
495,248
523,030
535,168
147,433
457,642
484,610
482,501
532,453
530,823
339,738
537,879
607,317
567,946
552,467
554,791
706,824
763,868
653,759
727,877
813,787
934,444
872,959
737,782
753,043
722,428
665,481
683,721
658,560
719,358
731,564
784,049
733,148
836,394
846,410
786,604
822,016
854,024
829,276
782,674
799,443
771,659
797,984
847,362
901,335
580,890
562,103
565,879
948,651
1,154,745
934,424
1,055,337
1,165,111
1,297,010
1,245,546
1,231,320
1,279,587
1,436,753
1,501,052
1,505,836
1,559,448
1,710,635
1,736,201
1,735,408
1,787,912
1,787,9121,735,4081,736,2011,710,6351,559,4481,505,8361,501,0521,436,7531,279,5871,231,3201,245,5461,297,0101,165,1111,055,337934,4241,154,745948,651565,879562,103580,890901,335847,362797,984771,659799,443782,674829,276854,024822,016786,604846,410836,394733,148784,049731,564719,358658,560683,721665,481722,428753,043737,782872,959934,444813,787727,877653,759763,868706,824554,791552,467567,946607,317537,879339,738530,823532,453482,501484,610457,642147,433535,168523,030495,248510,357466,105429,344396,751351,320317,810267,938250,098255,0440195,677149,008
       Other Current Assets 
506
1,608
0
2,167
2,129
2,638
931
698
1,030
5,950
3,521
4,264
4,587
4,207
6,412
372,245
4,843
4,126
489,354
535,727
534,478
149,247
4,501
612,492
36,605
558,892
1,249
1,759
772,599
57,981
737,395
824,216
945,835
883,983
94,969
766,963
735,748
676,465
697,337
33,041
759,215
745,975
797,048
30,494
851,505
866,073
803,762
837,942
872,890
851,146
808,964
821,950
789,310
815,860
867,315
919,918
964,145
953,248
971,502
967,718
1,182,769
963,386
1,079,008
1,185,447
1,320,723
1,271,433
1,257,474
1,308,859
1,457,186
1,523,547
1,533,940
2,064
2,366
6,562
6,719
30,092
30,0926,7196,5622,3662,0641,533,9401,523,5471,457,1861,308,8591,257,4741,271,4331,320,7231,185,4471,079,008963,3861,182,769967,718971,502953,248964,145919,918867,315815,860789,310821,950808,964851,146872,890837,942803,762866,073851,50530,494797,048745,975759,21533,041697,337676,465735,748766,96394,969883,983945,835824,216737,39557,981772,5991,7591,249558,89236,605612,4924,501149,247534,478535,727489,3544,1264,843372,2456,4124,2074,5874,2643,5215,9501,0306989312,6382,1292,16701,608506
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
39,733
0
0
47,579
50,133
48,968
59,492
0
68,926
68,626
72,851
67,838
86,657
86,282
94,612
102,241
131,004
131,433
244,278
425,313
460,687
459,603
464,519
469,565
480,685
479,981
479,510
506,413
639,522
643,255
682,158
690,076
1,019,277
1,029,113
1,052,362
998,037
974,028
988,748
984,767
950,951
937,068
1,130,184
1,127,595
1,128,559
1,087,596
1,127,683
1,172,080
1,190,651
1,276,923
1,313,009
1,358,504
1,397,385
1,450,887
1,429,178
1,366,122
1,363,922
1,384,500
1,375,734
1,366,219
1,373,724
1,398,559
1,398,5591,373,7241,366,2191,375,7341,384,5001,363,9221,366,1221,429,1781,450,8871,397,3851,358,5041,313,0091,276,9231,190,6511,172,0801,127,6831,087,5961,128,5591,127,5951,130,184937,068950,951984,767988,748974,028998,0371,052,3621,029,1131,019,277690,076682,158643,255639,522506,413479,510479,981480,685469,565464,519459,603460,687425,313244,278131,433131,004102,24194,61286,28286,65767,83872,85168,62668,926059,49248,96850,13347,5790039,733000000000000000
       Property Plant Equipment 
7,794
7,888
0
6,259
7,847
7,393
8,803
9,767
10,124
10,766
14,154
15,043
15,765
17,455
17,699
20,418
22,337
23,663
24,767
27,223
27,658
26,289
26,672
28,264
28,258
28,691
29,289
31,601
31,442
32,261
32,720
33,904
33,443
33,373
43,559
45,485
47,298
44,846
47,060
52,909
59,387
61,300
63,402
74,843
75,894
81,023
88,257
112,068
117,767
132,095
132,844
136,015
133,991
134,039
131,422
128,901
128,448
128,677
127,494
310,830
327,047
330,196
350,481
392,620
423,421
477,029
497,719
519,020
508,166
495,363
489,603
506,997
503,778
501,950
511,271
535,590
535,590511,271501,950503,778506,997489,603495,363508,166519,020497,719477,029423,421392,620350,481330,196327,047310,830127,494128,677128,448128,901131,422134,039133,991136,015132,844132,095117,767112,06888,25781,02375,89474,84363,40261,30059,38752,90947,06044,84647,29845,48543,55933,37333,44333,90432,72032,26131,44231,60129,28928,69128,25828,26426,67226,28927,65827,22324,76723,66322,33720,41817,69917,45515,76515,04314,15410,76610,1249,7678,8037,3937,8476,25907,8887,794
       Goodwill 
0
0
0
0
0
0
0
0
0
0
5,087
5,002
4,875
4,748
4,621
0
0
0
0
3,986
0
3,731
3,603
3,986
436
3,985
3,985
16,064
16,064
16,064
16,064
32,057
32,057
32,057
200,155
196,146
208,199
200,170
198,223
201,321
201,450
200,588
201,201
327,473
327,130
351,723
350,804
489,228
598,939
598,858
597,135
474,289
476,644
476,644
476,644
474,289
474,289
474,289
474,289
440,236
440,236
440,236
440,236
440,236
440,236
440,236
440,236
440,236
440,236
440,236
440,236
440,236
440,236
440,236
440,236
483,160
483,160440,236440,236440,236440,236440,236440,236440,236440,236440,236440,236440,236440,236440,236440,236440,236440,236474,289474,289474,289474,289476,644476,644476,644474,289597,135598,858598,939489,228350,804351,723327,130327,473201,201200,588201,450201,321198,223200,170208,199196,146200,15532,05732,05732,05716,06416,06416,06416,0643,9853,9854363,9863,6033,73103,98600004,6214,7484,8755,0025,0870000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
79,823
78,448
77,383
75,976
76,688
76,829
74,716
38,797
29,771
30,058
32,224
39,848
32,361
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000000032,36139,84832,22430,05829,77138,79774,71676,82976,68875,97677,38378,44879,82300000000000000000000000000000000000000000000000
       Intangible Assets 
0
16
0
1,895
16
16
16
673
602
491
6,032
6,545
6,921
7,274
7,301
7,560
7,690
7,658
7,311
6,984
6,625
8,431
7,988
8,720
8,039
4,315
6,017
24,358
24,271
24,226
25,658
46,612
45,963
50,970
269,577
294,849
307,122
291,705
288,528
257,975
256,618
255,713
255,955
428,328
426,569
450,775
449,423
235,843
843,495
720,934
718,763
207,595
204,377
201,992
198,466
196,859
373,468
366,661
358,632
188,523
186,340
185,006
184,666
184,240
182,396
184,897
184,969
184,096
181,293
177,695
177,196
179,241
177,661
178,701
178,253
177,668
177,668178,253178,701177,661179,241177,196177,695181,293184,096184,969184,897182,396184,240184,666185,006186,340188,523358,632366,661373,468196,859198,466201,992204,377207,595718,763720,934843,495235,843449,423450,775426,569428,328255,955255,713256,618257,975288,528291,705307,122294,849269,57750,97045,96346,61225,65824,22624,27124,3586,0174,3158,0398,7207,9888,4316,6256,9847,3117,6587,6907,5607,3017,2746,9216,5456,0324916026731616161,8950160
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
8,033
0
0
18,598
15,926
10,592
24,772
0
31,942
58,741
63,182
56,539
2,376
13,274
8,116
25,127
31,587
39,924
108,862
45,835
60,436
57,224
33,098
45,725
69,788
24,382
58,024
97,142
79,214
26,898
576,774
572,378
1
-721,213
839,456
836,633
30,744
-1
53,182
46,192
37,962
35,474
37,743
46,642
34,584
87,269
141,805
114,888
119,527
111,581
124,791
83,168
143,840
83,607
87,201
79,222
34,306
23,829
22,643
56,852
15,927
15,92756,85222,64323,82934,30679,22287,20183,607143,84083,168124,791111,581119,527114,888141,80587,26934,58446,64237,74335,47437,96246,19253,182-130,744836,633839,456-721,2131572,378576,77426,89879,21497,14258,02424,38269,78845,72533,09857,22460,43645,835108,86239,92431,58725,1278,11613,2742,37656,53963,18258,74131,942024,77210,59215,92618,598008,033000000000000000
> Total Liabilities 
215,822
268,650
0
345,974
341,302
331,271
400,431
372,086
354,571
353,637
339,826
482,021
408,925
447,737
473,307
448,045
406,538
378,642
374,403
465,917
504,113
356,604
435,160
551,687
571,334
472,837
445,143
672,813
726,768
646,354
624,544
859,673
1,038,738
1,064,509
1,168,265
1,207,102
1,175,004
1,112,935
1,057,094
1,139,364
1,321,171
1,187,118
1,314,774
1,614,213
1,648,019
1,525,125
1,458,449
1,953,277
2,024,067
2,000,090
1,864,557
1,873,560
1,647,934
1,675,737
1,692,224
1,869,013
2,030,579
2,066,507
2,165,313
2,178,756
2,580,257
2,397,825
2,278,163
2,325,846
2,683,486
2,472,039
2,344,817
2,557,006
3,059,666
2,785,997
2,653,715
2,854,339
3,293,268
3,098,949
3,132,316
3,398,901
3,398,9013,132,3163,098,9493,293,2682,854,3392,653,7152,785,9973,059,6662,557,0062,344,8172,472,0392,683,4862,325,8462,278,1632,397,8252,580,2572,178,7562,165,3132,066,5072,030,5791,869,0131,692,2241,675,7371,647,9341,873,5601,864,5572,000,0902,024,0671,953,2771,458,4491,525,1251,648,0191,614,2131,314,7741,187,1181,321,1711,139,3641,057,0941,112,9351,175,0041,207,1021,168,2651,064,5091,038,738859,673624,544646,354726,768672,813445,143472,837571,334551,687435,160356,604504,113465,917374,403378,642406,538448,045473,307447,737408,925482,021339,826353,637354,571372,086400,431331,271341,302345,9740268,650215,822
   > Total Current Liabilities 
209,901
199,364
0
294,725
275,156
257,982
323,908
241,866
234,758
233,255
218,948
285,166
242,205
271,058
290,172
312,499
270,474
234,619
229,729
354,478
393,077
238,660
320,071
432,253
451,490
331,480
303,523
509,541
565,867
492,549
472,844
690,950
847,907
680,722
732,002
725,680
712,366
706,224
691,785
782,674
931,705
840,468
1,003,894
1,187,526
1,233,727
1,040,308
950,530
1,156,942
1,244,683
1,268,226
1,244,133
1,576,748
1,380,529
1,333,550
1,115,663
1,411,729
1,475,226
1,517,376
1,561,484
1,575,927
1,961,673
1,777,378
1,623,863
1,543,856
1,959,725
1,746,794
1,522,296
1,716,886
2,266,576
2,012,717
1,942,913
1,956,323
2,470,706
2,319,578
2,425,423
2,446,645
2,446,6452,425,4232,319,5782,470,7061,956,3231,942,9132,012,7172,266,5761,716,8861,522,2961,746,7941,959,7251,543,8561,623,8631,777,3781,961,6731,575,9271,561,4841,517,3761,475,2261,411,7291,115,6631,333,5501,380,5291,576,7481,244,1331,268,2261,244,6831,156,942950,5301,040,3081,233,7271,187,5261,003,894840,468931,705782,674691,785706,224712,366725,680732,002680,722847,907690,950472,844492,549565,867509,541303,523331,480451,490432,253320,071238,660393,077354,478229,729234,619270,474312,499290,172271,058242,205285,166218,948233,255234,758241,866323,908257,982275,156294,7250199,364209,901
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
29,571
51,666
0
91,764
0
42,352
125,187
63,802
40,534
43,155
107,275
129,666
125,114
138,537
247,192
177,319
236,412
204,893
221,348
151,475
144,052
181,010
228,779
250,260
312,126
340,724
318,891
308,407
257,097
246,314
271,938
419,331
446,676
715,867
591,902
494,657
268,814
292,322
362,780
454,705
422,478
344,650
627,089
683,274
385,989
234,224
311,490
546,726
288,602
206,837
418,487
726,667
432,529
221,920
324,638
700,206
454,246
298,788
298,788454,246700,206324,638221,920432,529726,667418,487206,837288,602546,726311,490234,224385,989683,274627,089344,650422,478454,705362,780292,322268,814494,657591,902715,867446,676419,331271,938246,314257,097308,407318,891340,724312,126250,260228,779181,010144,052151,475221,348204,893236,412177,319247,192138,537125,114129,666107,27543,15540,53463,802125,18742,352091,764051,66629,571000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
608,707
670,370
773,788
446,676
715,867
591,902
494,657
268,814
292,322
314,143
396,948
369,245
344,650
569,042
626,121
385,989
167,474
239,294
467,289
204,390
117,653
331,986
638,380
346,723
131,015
231,496
609,838
363,259
206,276
206,276363,259609,838231,496131,015346,723638,380331,986117,653204,390467,289239,294167,474385,989626,121569,042344,650369,245396,948314,143292,322268,814494,657591,902715,867446,676773,788670,370608,70700000000000000000000000000000000000000000000000
       Accounts payable 
131,361
150,757
0
186,708
172,657
126,984
136,746
193,768
173,849
164,799
151,721
233,281
183,643
179,404
192,391
186,712
160,722
178,673
173,641
274,208
228,979
129,860
250,347
367,404
295,509
246,042
242,844
436,637
424,275
330,884
322,448
514,650
548,411
460,618
433,607
447,306
420,679
494,881
485,127
535,714
627,304
513,829
616,672
711,365
813,112
608,347
592,320
734,908
784,357
673,452
612,608
697,801
677,468
735,620
739,082
941,394
929,845
868,688
935,344
1,061,490
1,194,117
879,252
984,721
1,145,663
1,477,388
1,017,978
1,051,280
1,332,953
1,640,300
1,062,773
1,288,389
1,507,143
1,895,696
1,359,152
1,720,544
1,869,847
1,869,8471,720,5441,359,1521,895,6961,507,1431,288,3891,062,7731,640,3001,332,9531,051,2801,017,9781,477,3881,145,663984,721879,2521,194,1171,061,490935,344868,688929,845941,394739,082735,620677,468697,801612,608673,452784,357734,908592,320608,347813,112711,365616,672513,829627,304535,714485,127494,881420,679447,306433,607460,618548,411514,650322,448330,884424,275436,637242,844246,042295,509367,404250,347129,860228,979274,208173,641178,673160,722186,712192,391179,404183,643233,281151,721164,799173,849193,768136,746126,984172,657186,7080150,757131,361
       Other Current Liabilities 
19,571
21,661
0
35,333
31,219
31,793
27,236
20,730
20,186
24,248
27,811
35,891
42,960
28,356
38,813
312,499
30,547
27,661
8,038
6,890
164,098
9,385
18,389
12,671
14,925
12,979
10,403
12,332
9,614
13,176
13,776
14,026
40,407
42,785
25,803
26,140
27,682
20,324
22,559
19,177
21,037
21,507
23,864
68,779
31,726
61,140
57,829
111,395
121,136
112,041
125,696
103,381
11,534
52,540
58,181
130,727
137,394
99,800
101,974
55,503
76,962
94,561
59,437
80,241
90,831
119,744
115,420
177,096
207,789
223,277
221,995
227,260
250,372
260,220
250,633
246,601
246,601250,633260,220250,372227,260221,995223,277207,789177,096115,420119,74490,83180,24159,43794,56176,96255,503101,97499,800137,394130,72758,18152,54011,534103,381125,696112,041121,136111,39557,82961,14031,72668,77923,86421,50721,03719,17722,55920,32427,68226,14025,80342,78540,40714,02613,77613,1769,61412,33210,40312,97914,92512,67118,3899,385164,0986,8908,03827,66130,547312,49938,81328,35642,96035,89127,81124,24820,18620,73027,23631,79331,21935,333021,66119,571
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
135,546
0
0
144,674
111,439
111,036
117,944
0
119,434
119,844
141,357
141,620
163,272
160,901
153,805
151,700
168,723
190,831
383,787
436,263
481,422
462,638
406,711
365,309
356,690
389,466
346,650
310,880
426,687
414,292
484,817
507,919
796,335
779,384
731,864
620,424
296,812
267,405
342,187
576,561
457,284
555,353
549,131
603,829
602,829
618,584
620,447
654,300
781,990
723,761
725,245
822,521
840,120
793,090
773,280
710,802
898,016
822,562
779,371
706,893
952,256
952,256706,893779,371822,562898,016710,802773,280793,090840,120822,521725,245723,761781,990654,300620,447618,584602,829603,829549,131555,353457,284576,561342,187267,405296,812620,424731,864779,384796,335507,919484,817414,292426,687310,880346,650389,466356,690365,309406,711462,638481,422436,263383,787190,831168,723151,700153,805160,901163,272141,620141,357119,844119,4340117,944111,036111,439144,67400135,546000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
503,216
497,257
521,510
515,372
541,666
666,495
613,280
621,231
721,152
740,045
686,978
674,254
613,938
802,271
729,639
683,400
618,206
0
0618,206683,400729,639802,271613,938674,254686,978740,045721,152621,231613,280666,495541,666515,372521,510497,257503,2160000000000000000000000000000000000000000000000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-29,571
-51,666
0
-91,764
0
-42,352
-125,187
-63,802
-40,534
-43,155
-107,275
-129,666
-125,114
-138,537
-247,192
-177,319
-236,412
-204,893
-221,348
-151,475
-144,052
-181,010
-228,779
-250,260
-312,126
-340,724
-318,891
-308,407
-257,097
-246,314
-271,938
-419,331
-446,676
-715,867
-591,902
-494,657
-268,814
-292,322
-141,110
-234,579
-205,965
-344,650
-381,033
-435,435
-182,404
65,385
15,190
-181,547
87,633
181,592
-38,718
-362,396
-77,026
138,608
35,345
-341,605
-91,893
65,006
65,006-91,893-341,60535,345138,608-77,026-362,396-38,718181,59287,633-181,54715,19065,385-182,404-435,435-381,033-344,650-205,965-234,579-141,110-292,322-268,814-494,657-591,902-715,867-446,676-419,331-271,938-246,314-257,097-308,407-318,891-340,724-312,126-250,260-228,779-181,010-144,052-151,475-221,348-204,893-236,412-177,319-247,192-138,537-125,114-129,666-107,275-43,155-40,534-63,802-125,187-42,3520-91,7640-51,666-29,571000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
173,756
0
0
0
0
0
0
0
0
8,018
0
0
0
0
0
0
0
00000008,01800000000173,75600000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
52,287
67,686
67,686
79,946
84,052
88,902
104,139
404,474
413,023
424,918
436,683
445,713
454,956
457,294
455,235
467,440
472,803
480,387
478,676
485,366
493,436
505,626
510,660
518,887
521,389
529,427
537,433
545,035
555,000
558,603
569,535
561,138
568,502
577,555
578,216
573,214
542,907
729,249
708,845
688,851
681,318
681,549
675,237
667,946
708,695
807,131
797,602
758,956
831,523
806,688
771,398
745,932
1,029,078
1,026,416
1,018,987
1,021,211
983,149
984,326
984,289
1,004,632
1,005,413
1,001,002
1,018,719
1,046,324
1,055,218
1,088,960
1,111,025
1,086,070
1,097,725
1,165,641
1,205,210
1,191,014
1,184,610
1,199,716
1,261,606
1,248,348
1,248,3481,261,6061,199,7161,184,6101,191,0141,205,2101,165,6411,097,7251,086,0701,111,0251,088,9601,055,2181,046,3241,018,7191,001,0021,005,4131,004,632984,289984,326983,1491,021,2111,018,9871,026,4161,029,078745,932771,398806,688831,523758,956797,602807,131708,695667,946675,237681,549681,318688,851708,845729,249542,907573,214578,216577,555568,502561,138569,535558,603555,000545,035537,433529,427521,389518,887510,660505,626493,436485,366478,676480,387472,803467,440455,235457,294454,956445,713436,683424,918413,023404,474104,13988,90284,05279,94667,68667,68652,287
   Common Stock
41,255
41,255
0
41,255
41,255
41,255
83,078
393,578
393,578
393,578
393,578
393,578
393,578
393,578
390,415
393,578
393,578
393,578
393,578
393,578
393,578
395,087
395,087
395,087
395,087
395,087
395,087
396,084
396,084
396,084
397,895
397,895
397,895
397,895
400,112
400,112
400,112
586,879
586,879
586,879
586,879
586,879
586,879
586,879
586,879
726,852
726,852
726,852
826,549
826,549
826,549
826,549
1,143,070
1,141,483
1,141,483
1,159,065
1,159,065
1,159,065
1,159,065
1,159,065
1,159,065
1,159,065
1,159,065
1,043,663
1,043,663
1,043,663
1,043,663
1,043,663
1,043,663
1,043,663
1,043,663
1,043,663
1,043,663
1,043,663
1,043,663
1,043,663
1,043,6631,043,6631,043,6631,043,6631,043,6631,043,6631,043,6631,043,6631,043,6631,043,6631,043,6631,043,6631,043,6631,159,0651,159,0651,159,0651,159,0651,159,0651,159,0651,159,0651,159,0651,141,4831,141,4831,143,070826,549826,549826,549826,549726,852726,852726,852586,879586,879586,879586,879586,879586,879586,879586,879400,112400,112400,112397,895397,895397,895397,895396,084396,084396,084395,087395,087395,087395,087395,087395,087393,578393,578393,578393,578393,578393,578390,415393,578393,578393,578393,578393,578393,578393,57883,07841,25541,25541,255041,25541,255
   Retained Earnings 
10,954
26,353
0
28,928
30,128
33,656
14,390
1,921
7,010
15,282
23,446
28,053
33,050
39,634
40,738
37,584
44,322
49,186
37,776
37,477
7,757
56,647
61,358
41,437
45,389
11,669
20,162
49,174
9,542
21,971
32,795
168,908
6,943
19,583
24,956
180,247
-13,536
-11,395
-31,961
-63,125
-70,761
-70,635
-77,016
-84,307
-93,558
-85,095
-94,624
-133,270
-160,400
-185,235
-33,700
-245,991
-279,366
-280,441
-287,870
-285,646
-323,708
-322,531
-322,568
-302,225
-301,444
-305,855
-277,557
52,334
8,894
42,636
67,192
97,350
-6,252
59,980
76,310
156,974
-5,006
9,821
41,982
180,071
180,07141,9829,821-5,006156,97476,31059,980-6,25297,35067,19242,6368,89452,334-277,557-305,855-301,444-302,225-322,568-322,531-323,708-285,646-287,870-280,441-279,366-245,991-33,700-185,235-160,400-133,270-94,624-85,095-93,558-84,307-77,016-70,635-70,761-63,125-31,961-11,395-13,536180,24724,95619,5836,943168,90832,79521,9719,54249,17420,16211,66945,38941,43761,35856,6477,75737,47737,77649,18644,32237,58440,73839,63433,05028,05323,44615,2827,0101,92114,39033,65630,12828,928026,35310,954
   Capital Surplus 0000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock00000000-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367000-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-16,367-13,639-7,255-11,433-10,124-10,124-10,124-10,124-7,993-850-850-850000-1,058-1,05800-19,114-4,025-6,441-4,766000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
73,862
0
0
47,322
54,311
92,101
53,892
0
82,363
80,913
122,671
122,184
148,951
149,374
140,548
138,845
163,243
163,664
160,077
153,148
173,102
156,331
153,765
153,927
165,097
165,200
165,305
165,374
165,374
215,374
165,374
165,374
165,374
165,374
165,374
-21,451
165,374
165,374
165,374
165,374
147,792
147,792
147,792
147,792
147,792
147,792
147,792
137,211
2,661
2,661
2,661
170
42,407
60,314
61,998
74,457
-173,341
-11,361
-26,188
-58,349
-196,438
-196,438-58,349-26,188-11,361-173,34174,45761,99860,31442,4071702,6612,6612,661137,211147,792147,792147,792147,792147,792147,792147,792165,374165,374165,374165,374-21,451165,374165,374165,374165,374165,374215,374165,374165,374165,305165,200165,097153,927153,765156,331173,102153,148160,077163,664163,243138,845140,548149,374148,951122,184122,67180,91382,363053,89292,10154,31147,3220073,862000000000000000



Balance Sheet

Currency in BRL. All numbers in thousands.




Cash Flow

Currency in BRL. All numbers in thousands.




Income Statement

Currency in BRL. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue8,661,744
Cost of Revenue-7,369,775
Gross Profit1,291,9691,291,969
 
Operating Income (+$)
Gross Profit1,291,969
Operating Expense-1,046,351
Operating Income245,618245,618
 
Operating Expense (+$)
Research Development0
Selling General Administrative242,835
Selling And Marketing Expenses803,516
Operating Expense1,046,3511,046,351
 
Net Interest Income (+$)
Interest Income10,950
Interest Expense-168,313
Other Finance Cost-16,465
Net Interest Income-140,898
 
Pretax Income (+$)
Operating Income245,618
Net Interest Income-140,898
Other Non-Operating Income Expenses0
Income Before Tax (EBT)81,582409,654
EBIT - interestExpense = 77,305
74,132
238,710
Interest Expense168,313
Earnings Before Interest and Taxes (EBIT)245,618249,895
Earnings Before Interest and Taxes (EBITDA)394,138
 
After tax Income (+$)
Income Before Tax81,582
Tax Provision-3,735
Net Income From Continuing Ops77,85877,847
Net Income70,397
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses8,416,126
Total Other Income/Expenses Net-164,036140,898
 

Technical Analysis of Profarma
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Profarma. The general trend of Profarma is BULLISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Profarma's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (100.0%) Bearish trend (-100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Profarma Distribuidora de Produtos Farmacêuticos S.A.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: .

The bearish price targets are: 5.92 > 5.79 > 5.18.

Tweet this
Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current mas is .

The long score for the Moving Averages is 14/14.
The longshort score for the Moving Averages is 14/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current macd is 0.14486861.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Profarma price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Profarma. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Profarma price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Moving Average Convergence/Divergence (MACD) ChartProfarma Distribuidora de Produtos Farmacêuticos S.A Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current adx is 19.61.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Profarma shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current sar is 5.22727776.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current rsi is 70.36. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending up: The RSI is trending up. +1
Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Relative Strength Index (RSI) ChartProfarma Distribuidora de Produtos Farmacêuticos S.A Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current phase is Overbought in bull market.

The long score for the Stochastic Oscillator is 6/6.
The longshort score for the Stochastic Oscillator is 6/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH > 80: The STOCH %K is above 80 and overbought. +2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Profarma price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Stochastic Oscillator ChartProfarma Distribuidora de Produtos Farmacêuticos S.A Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current cci is 247.88.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Commodity Channel Index (CCI) ChartProfarma Distribuidora de Produtos Farmacêuticos S.A Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current cmo is 54.78.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Chande Momentum Oscillator (CMO) ChartProfarma Distribuidora de Produtos Farmacêuticos S.A Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current willr is -4.95867769.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Williams %R ChartProfarma Distribuidora de Produtos Farmacêuticos S.A Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Profarma Distribuidora de Produtos Farmacêuticos S.A.

Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current atr is 0.27343478.

Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Average True Range (ATR) ChartProfarma Distribuidora de Produtos Farmacêuticos S.A Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current obv is 3,012,300.

Profarma Distribuidora de Produtos Farmacêuticos S.A Daily On-Balance Volume (OBV) ChartProfarma Distribuidora de Produtos Farmacêuticos S.A Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Profarma Distribuidora de Produtos Farmacêuticos S.A. The current mfi is 77.90.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Money Flow Index (MFI) ChartProfarma Distribuidora de Produtos Farmacêuticos S.A Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Profarma Distribuidora de Produtos Farmacêuticos S.A.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-01SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05RSI SHORT ENTRY LONG CLOSE70 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-11CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-12-12RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-15STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-18STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-21STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-26STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-08CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-10STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-30WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-31STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-06STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-14STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-19DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-20CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-29STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-01RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-06MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-15DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-20CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-21SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-28MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-10STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-24STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Profarma Distribuidora de Produtos Farmacêuticos S.A Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Profarma Distribuidora de Produtos Farmacêuticos S.A based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.356
Ma 20Greater thanMa 505.573
Ma 50Greater thanMa 1005.458
Ma 100Greater thanMa 2005.278
OpenGreater thanClose6.070
Total4/5 (80.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Profarma with someone you think should read this too:
  • Are you bullish or bearish on Profarma? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Profarma? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Profarma Distribuidora de Produtos Farmacêuticos S.A

I send you an email if I find something interesting about Profarma Distribuidora de Produtos Farmacêuticos S.A.


Comments

How you think about this?

Leave a comment

Stay informed about Profarma Distribuidora de Produtos Farmacêuticos S.A.

Receive notifications about Profarma Distribuidora de Produtos Farmacêuticos S.A in your mailbox!